4 Long-term Effects of Weight Loss Drugs You Should Know About
Weight-loss drugs, or GLP-1 agonists, have become more popular among patients seeking to achieve a healthy weight. As their popularity continues to grow, an important question remains: What happens in the long run? What are the benefits and potential concerns associated with long-term use? At EndoSlim Clinic of Atlantic Gastroenterology in Brooklyn, New York, we are here to help you understand the long-term effects of using medications such as semaglutide (Wegovy®) and tirzepatide (Zepbound®).
1. Sustainable weight loss
One of the biggest shifts in modern medicine is the recognition that obesity is a chronic disease rather than simply a lifestyle issue. Like high blood pressure or diabetes, obesity often requires ongoing management.
GLP-1 receptor agonists regulate appetite, slow stomach emptying, improve blood sugar control, and increase feelings of fullness. These effects help patients consume fewer calories and lose substantial amounts of weight. For many individuals struggling with obesity, these medications offer renewed hope, improved health, and a better quality of life.
2. Cardiovascular benefits
One of the most exciting developments of GLP-1s is the discovery that these medications do more than promote weight loss.
Research has demonstrated benefits involving:
- Heart health.
- Blood pressure.
- Inflammation.
- Kidney function.
- Metabolic health.
We know obesity increases the risk of several diseases, including heart disease. While more research needs to be done, available data show that these medications can help reduce the risk of cardiovascular-related conditions.
3. Addressing alcohol addiction
Some studies have revealed that weight loss drugs have promising results for addressing alcohol and drug addiction. In addition to their inhibitory effects on the gastrointestinal system, GLP-1s interact with parts of the brain that control reward, motivation, and impulses. While there is room for more research, available studies have shown that GLP-1 drugs can help reduce cravings by influencing the brain’s reward pathways, which play a key role in addictive behaviors.
4. Weight regain risk
According to a study published in Nature Reviews Endocrinology, many patients can regain weight after stopping medication. The research also postulates that weight regain may lead to deterioration of many of the cardiometabolic improvements achieved during treatment. This doesn’t mean the medications fail. Rather, it reinforces the understanding that obesity is a chronic condition that often requires ongoing treatment and lifestyle management.
Overall, GLP-1 medications have demonstrated a strong safety profile in clinical trials and real-world use. Most side effects, such as nausea, vomiting, and diarrhea, occur early in treatment and improve over time. The primary reason many patients discontinue therapy is gastrointestinal intolerance or cost rather than serious medical complications.
Are weight loss drugs a lifetime commitment?
For many patients, the answer may be yes. Obesity behaves similarly to other chronic diseases. Just as stopping blood pressure medication often causes blood pressure to rise again, discontinuing weight-loss medication often leads to weight regain and a reversal of health improvements.
That doesn’t mean every patient must remain on medication indefinitely. Some individuals successfully transition to maintenance strategies involving nutrition, exercise, lifestyle changes, and close medical supervision. At our Brooklyn practice, long-term planning is part of every treatment discussion.
Where can I learn more about weight loss drugs in the Brooklyn area?
At EndoSlim Clinic of Atlantic Gastroenterology, we are the leading provider of medically assisted weight loss in the Brooklyn, NY, area. We also have an office in Coral Springs, FL. If you have concerns or want to get started with weight loss, we are here to help. Call 718 521-2840 and schedule an appointment with our team.
Share this Article
Back to Home Page